MedAnnex
Latest round
- Series B
Last raised
- Jul 2019
Total raised
- $13M
Investors
- 2
About MedAnnex
MedAnnex Ltd. is a biotechnology company focused on developing innovative immunotherapy treatments aimed at cancer and autoimmune diseases.Founded in 2009 and headquartered in Edinburgh, UK, MedAnnex Ltd. specializes in biopharmaceuticals targeting immunotherapy applications.75 million.MedAnnex Ltd specializes in the development of innovative immunotherapy treatments targeting annexin-A1, a protein implicated in cancer cell growth and autoimmune diseases. Their flagship product, MDX-124, is a first-in-class monoclonal antibody designed to inhibit the action of annexin-A1, potentially reducing cancer cell proliferation and migration. Currently, this product is undergoing a Phase 1b clinical study focused on cancer patients, with plans for further clinical studies in autoimmune diseases. MedAnnex collaborates with leading clinical experts and institutions to evaluate the therapeutic and commercial potential of its proprietary technology, which serves a diverse range of patients affected by various cancers and autoimmune conditions.Details regarding MedAnnex's revenue generation structure are not publicly disclosed. The company operates through partnerships and collaborations with clinical research organizations and healthcare institutions, facilitating transactions related to clinical trial services and product development.In July 2019, MedAnnex Ltd. The funds will support the advancement of MDX-124 and further clinical studies, particularly focusing on outcomes in cancer and autoimmune therapies. The company aims to expand its presence in European markets, engaging with new partnerships and collaborations to enhance its research capabilities and market reach.
Who invested in MedAnnex
2 investors across 1 round
See all investors in MedAnnex
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 22, 2019
Amount
$13M
Investors
Questions about MedAnnex
Who invested in MedAnnex?
MedAnnex has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MedAnnex raised?
MedAnnex has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MedAnnex last raise money?
MedAnnex's most recent round on record is a Series B, in Jul 2019.
What does MedAnnex do?
MedAnnex is a biotechnology company.
Where is MedAnnex headquartered?
MedAnnex is headquartered in Edinburgh, UK.
Which VCs invest in companies like MedAnnex?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at MedAnnex's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like MedAnnex? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.